PD-L1, beyond its immune checkpoint function, directly promotes VM in NSCLC through ZEB1-mediated EMT activation, with knockdown reducing tube formation by 62% and suppressing VE-cadherin/MMP9 expression (6). This evidence concerns the gene CD274 and non-small cell lung carcinoma.